Hitting the mother lode of tumor angiogenesis. [PDF]
Nat Biotechnol, 2008 James D, Rabbany S, Rafii S.
europepmc +1 more source
Inhibition of expression of vascular endothelial growth factor and its receptors in pulmonary adenocarcinoma cell by TNP-470 in combination with gemcitabine. [PDF]
J Zhejiang Univ Sci B, 2006 Wang XF, Tu LF, Wang LH, Zhou JY.
europepmc +1 more source
TNP-470 skews DC differentiation to Th1-stimulatory phenotypes and can serve as a novel adjuvant in a cancer vaccine. [PDF]
Blood Adv, 2018 Ho DH, Wong RH.
europepmc +1 more source
MetAP2 as a Therapeutic Target for Obesity and Type 2 Diabetes: Structural Insights, Mechanistic Roles, and Inhibitor Development. [PDF]
BiomoleculesMoon DO.
europepmc +1 more source
The angiogenic inhibitor TNP-470 decreases caloric intake and weight gain in high-fat fed mice. [PDF]
Obesity (Silver Spring), 2012 White HM, Acton AJ, Considine RV.
europepmc +1 more source
Embryonic vascular disruption adverse outcomes: Linking high throughput signaling signatures with functional consequences. [PDF]
Reprod Toxicol, 2017 Ellis-Hutchings RG +6 more
europepmc +1 more source
Structure of a microsporidian methionine aminopeptidase type 2 complexed with fumagillin and TNP-470. [PDF]
Mol Biochem Parasitol, 2009 Alvarado JJ +7 more
europepmc +1 more source
<i>Aspergillus fumigatus</i> from Pathogenic Fungus to Unexplored Natural Treasure: Changing the Concept. [PDF]
J Microbiol BiotechnolIbrahim SRM +6 more
europepmc +1 more source
Antiangiogenesis and vascular endothelial growth factor/vascular endothelial growth factor receptor targeting as part of a combined-modality approach to the treatment of cancer. [PDF]
Int J Radiat Oncol Biol Phys, 2007 O'Reilly MS.
europepmc +1 more source
Preclinical therapeutic response of residual metastatic disease is distinct from its primary tumor of origin. [PDF]
Int J Cancer, 2012 Day CP +4 more
europepmc +1 more source